Xaviat 15mg & 20mg Tablet
PDF Leaflet Revision Date: July 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Prevention of stroke and systemic embolism in non-valvular atrial fibrillation, treatment and prevention of DVT and PE.
Dosage (summary)
SPAF: 20 mg once daily; moderate renal impairment: 15 mg once daily. DVT/PE: 15 mg twice daily for 3 weeks, then 20 mg once daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- Other anticoagulants
- NSAIDs
Contraindications
- Hypersensitivity
- Active bleeding
- Severe hepatic disease
- Pregnancy
- Lactation
Common side effects
- Anaemia
- Dizziness
- Gingival bleeding
- Gastrointestinal bleeding
Counselling Points
- Take with food
- Report any signs of bleeding
- Do not double dose if missed
Serious warnings
- Increased bleeding risk
- Monitor for signs of bleeding
- Use with caution in renal impairment
Important Disclaimer
The Xaviat 15mg & 20mg Tablet professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
